SLDB · Solid Biosciences Inc
United States · RS rating 33 · As of 2026-11-03
| Price | 6.28 USD |
|---|---|
| 1-day change | +4.7% |
| RS rating (overall / 1M / 3M / 12M) | 33 / 33 / 22 / 65 |
| Stage | Basing |
| Composite / Minervini / CANSLIM score | 31 / 25 / 40 |
| Industry group (rank) | Medical-Biomed/Biotech (154) |
| EPS growth Q/Q | +26.9% |
| Sales growth Q/Q | – |
| Distance from 52-week high | +43.7% |
| Market cap (USD) | $808.8M |